Hälsa Hemma, a Swedish primary care innovator, secures funding from Sciety to enhance its scalable model combining digital consultations with home visits, addressing the growing demand for accessible healthcare.

Target Information

Hälsa Hemma is an innovative primary care provider based in Sweden that has developed a scalable model to enhance healthcare delivery. By combining digital consultations with physical home visits, the company aims to provide a more efficient and personal patient experience while improving resource utilization in healthcare. Operating within the public reimbursement framework, Hälsa Hemma generates recurring revenue from registered patients, establishing itself as a pivotal player in the Swedish primary care system.

Currently, Hälsa Hemma maintains an EBITDA-positive status with an annual revenue run rate of approximately SEK 60 million. The company has experienced impressive growth and operates in major cities like Stockholm, Gothenburg, and Malmö/Lund, covering a population of over 5.5 million residents.

Industry Overview in Sweden

The primary care industry in Sweden is evolving due to an increased demand for accessibility, continuity, and efficiency in healthcare services. As the healthcare landscape shifts towards patient-centric models, more care is being transi